Fortitude Advisory Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
CWP
DADC
Fortitude Advisory Group's PFE Position: Q2 2026 in Review
Fortitude Advisory Group reduced its Pfizer (PFE) stake by 4.6% in Q2 2026, selling an estimated $12.3K and leaving 9,700 shares worth $234K. The position accounts for 0.09% of the portfolio, ranked #200.
Fortitude Advisory Group first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.17M in Q4 2021. 1,132 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Fortitude Advisory Group held 9,700 shares of Pfizer worth $234K as of Q2 2026.
- Fortitude Advisory Group sold 469 Pfizer shares in Q2 2026, an estimated $12.3K.
- Pfizer made up 0.09% of Fortitude Advisory Group's portfolio in Q2 2026, its #200 holding.
- Fortitude Advisory Group first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- Fortitude Advisory Group's Pfizer position peaked at $1.17M in Q4 2021.
- 1,132 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Fortitude Advisory Group's 13F filing for Q2 2026, filed 22 Jul 2026.